Understanding the Investigator Usage of Individual Pharmaceutical Companies; the Pfizer Case
With Open Payments it is possible for Pfizer to better understand its own investigator usage pattern and how that pattern may differ from the practices of other pharmaceutical companies.
Investigator Detail in Open Payments
With Open Payments US investigator names and experience will become public knowledge.
The US and the Location of Clinical Sites
More recent ClinicalTrials.gov data indicate that the United States remains the central location for clinical trial activity.
Non-Commercial Clinical Trial: An Underappreciated Source of Clinical Investigators
With the pharmaceutical industry looking for new investigators, a non-commercial clinical trial has become an under appreciated source.
Hospitals and Private Practice: US Clinical Trial Locations
A data analysis focusing on where US investigators conduct clinical trials.